iGenics › AREDS2 Research Context
AREDS2 Research Context
AREDS and AREDS2 were large National Eye Institute studies of nutritional supplements for people at particular stages of age-related macular degeneration.
Major NEI Findings
| Question | NEI Context |
|---|---|
| Who May Benefit? | Some people with intermediate AMD, or late AMD in one eye, may benefit from an appropriate AREDS2 formula. |
| Does It Prevent AMD? | NEI says AREDS/AREDS2 supplements do not prevent AMD from starting. |
| Does It Treat Cataracts? | NEI says the formulas did not affect cataract. |
| Should Everyone Take It? | No. NEI recommends discussing the risks and benefits with an eye doctor. |
iGenics Is Not Identical to the Studied Formula
- iGenics contains the same broad nutrient categories, including lutein, zeaxanthin, vitamin C, vitamin E, zinc and copper.
- Its published label doses differ from the standard AREDS2 study formula.
- It adds bilberry, turmeric, ginkgo, black pepper extract and saffron.
- The complete iGenics combination has not been shown here to have an NEI-sponsored clinical trial.